This opportunity is no longer accepting applications.
grant HT942524MSRPCTA

DoD Multiple Sclerosis, Clinical Trial Award

The FY24 MSRP CTA grant supports clinical trials aimed at significantly improving the treatment or management of multiple sclerosis. There are two funding levels available:

  1. Funding Level 1 (CTA-FL1): Supports small, early-phase trials to demonstrate feasibility or help design larger trials. Preliminary data, particularly in MS subjects, are required.

  2. <…

The MSRP CTA supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical…

Funding Source

Agency: Dept. of the Army -- USAMRAA
Program: SBIR

Awards & funding

Total Funding: $8M
Total Awards Given 3

Dates

Opportunity Released: April 19, 2024
Open for Submission: April 19, 2024
Submission Deadline: October 7, 2024
Application Window Closes: October 7, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.